论文部分内容阅读
Objective: A phase Ⅱ study was conducted to determine the clinical efficacy and toxicity ofpemetrexed and low-dose cisplatin concurrent selective lymph node (SLN) late course accelerated hyper-fractionated (LCAF) intensity modulated radiotherapy(IMRT) in patients with locally advanced esophageal squamous cell carcinoma (ESCC).